Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (1702)	2/21/2006 3:30:55 PM
From: Jibacoa	Read Replies (1) \| Respond to of 1728

AFFX has been trying to form base at the 35 level.<g> Earnings in the last 2Qs were lower in spite of continued better revenues. Besides Perlegen's potential, what do you think of its collaboration with Iconix in the field of toxicogenomics ? The stock may get some help from the presentation on Tuesday next week in Washington,D.C. I am looking for it to close its Jan.6 downgap above the 44 level.(which would be a 28% gain from its recent "base".<g>) bigcharts.marketwatch.com RAGL Bernard